| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.029 | 0.6 |